Hypothesis

Autophagy does not merely recycle bulk cytoplasm; it follows a strict, signal‑dependent hierarchy that determines which organelles or proteins are degraded first. We propose that aging and malignant transformation perturb this hierarchy—not the overall flux—such that protective cargo (e.g., healthy mitochondria) is prematurely consumed while deleterious species (e.g., ubiquitinated protein aggregates or tumor‑suppressor proteins) are spared. This miss‑ordered degradation creates a cascade of proteotoxic stress that fuels age‑related decline and provides cancer cells with a selective advantage under stress.

Mechanistic Basis

Recent work shows that autophagy selectivity relies on cargo receptors (p62/SQSTM1, NBR1, OPTN, NDP52) whose affinity for LC3 is tuned by phosphorylation and receptor clustering [1][2]. Cargo‑induced membrane formation further enforces order by initiating phagophores at specific damaged sites [1]. We add a novel layer: a degradation timer set by sequential phosphorylation events that progressively lower the affinity threshold of each receptor class. Early stress activates ULK1‑dependent phosphorylation of OPTN, boosting its LC3 binding and targeting mitochondria for mitophagy. Subsequent AMPK‑mediated phosphorylation of p62 reduces its affinity, delaying aggregate clearance until mitochondrial damage is resolved. In aged cells, chronic oxidative stress alters kinase/phosphatase balances, causing premature p62 phosphorylation and thus early aggregate consumption, leaving mitochondria vulnerable. Cancer cells hijack this timer by overexpressing specific phosphatases that sustain high OPTN affinity, diverting autophagy toward degradation of pro‑apoptotic factors (e.g., BIM) while sparing oncogenic metabolites.

Experimental Plan

1. Generate temporal cargo maps – Fuse TurboID to OPTN, p62, and NDP52 with a degron‑controlled inducible system. After acute starvation or hypoxia, activate TurboID for 5‑min pulses at 0, 15, 30, 60 min and biotinylate proximal proteins. Streptavidin enrichment followed by LC‑MS/MS quantifies substrate order.
2. Compare young vs. senescent fibroblasts – Measure changes in the phosphorylation status of each receptor (phospho‑specific antibodies) and correlate with shifts in cargo capture timing.
3. Test cancer cell lines – Use CRISPR to knock‑in a phospho‑dead OPTN mutant (S177A) and assess whether mitophagy precedence is lost and BIM degradation increases under chemotherapy.
4. Functional read‑outs – Monitor mitochondrial membrane potential (TMRE), aggregate load (filter‑trap assay), and cell viability. In vivo, express the same reporters in murine liver (aged) and tumor xenografts to assess tissue‑specific hierarchy.

Expected Outcomes and Falsifiability

If the hierarchy model is correct, we will observe:

• A consistent, phosphorylation‑dependent sequence of substrate enrichment that shifts with age or oncogenic signaling.
• Phospho‑dead OPTN abolishes early mitochondrial uptake and accelerates aggregate clearance in young cells, mimicking the aged pattern.
• Restoring normal phosphorylation dynamics (via kinase activators or phosphatase inhibitors) rescues mitochondrial function and reduces tumorigenic growth. Falsification would occur if temporal TurboID labeling reveals no change in substrate order across conditions, or if manipulating receptor phosphorylation fails to alter cargo selectivity despite verified modification status. Such results would indicate that autophagy selectivity is governed by alternative mechanisms, refuting the proposed degradation timer hypothesis.